Selenium and thyroid hormone axis in critical ill states: An overview of conflicting view points

Journal of Trace Elements in Medicine and Biology

Volumn 23, Issue 2, 2009, Pages 71-74

  Gärtner, Roland ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Critically ill; Deiodinases; Non thyroidal illness; Selenoenzymes; Thyroid hormone

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; LIOTHYRONINE; SELENIUM; SELENOENZYME; SELENOPROTEIN; SODIUM SELENITE; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE 5 DEIODINASE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; CLINICAL TRIAL; CRITICAL ILLNESS; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INHIBITION; EUTHYROID SICK SYNDROME; HUMAN; IMMUNE SYSTEM; LIOTHYRONINE BLOOD LEVEL; MINERAL INTAKE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SELENIUM BLOOD LEVEL; SELENIUM DEFICIENCY; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CRITICAL ILLNESS; HUMANS; IODIDE PEROXIDASE; SELENIUM; SELENOPROTEINS; THYROID HORMONES; TRIIODOTHYRONINE;

EID: 65049090495     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2009.01.001     Document Type: Review

References (32)

1. Kaptein E.M., Weiner J.M., Robinson W.J., Wheeler W.S., and Nicoloff J.T. Relationship of altered thyroid hormone indices to survival in nonthyroidal illness. Clin Endocrinol 16 (1982) 565-574
2. McIver B., and Gorman C.A. Euthyroid sick syndrome: an overview. Thyroid 7 (1997) 125-132
3. Maehira F., Luyo G.A., Ikuko Miyagi I., Oshiro M., Yamane N., Kuba M., et al. Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clin Chim Acta 316 (2002) 137-146
4. Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guigo R., et al. Characterization of mammalian selenoproteomes. Science 300 (2003) 1439-1443
5. Böck A., Forchhammer K., Heider J., Leinfelder W., Sawers G., Veprek B., et al. Selenocysteine: the 21st amino acid. Mol Microbiol 5 (1991) 515-520
6. Lei X.G., Cheng W.H., and McClung J.P. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 27 (2007) 41-61
7. Brigelius-Flohé R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387 (2006) 1329-1335
8. Go Y.M., and Jones D.P. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 1780 (2008) 1273-1290
9. Flaring U.B., Rooyackers O.E., Wernerman J., and Hammarqvist F. Temporal changes in muscle glutathione in ICU patients. Intensive Care Med 29 (2003) 2193-2198
10. Beck M.A., Nelson H.K., Shi Q., Van Dael P., Schiffrin E.J., Blum S., et al. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J 15 (2001) 1481-1483
11. Vunta H., Davis F., Palempalli U.D., Bhat D., Arner R.J., Thompson J.T., et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem 282 (2007) 17964-17973
12. Hollenbach B., Morgenthaler N.G., Struck J., Alonso C., Bergmann A., Köhrle J., et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 22 (2008) 24-32
13. Burk R.F., and Hill K.E. Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 25 (2005) 215-235
14. Forceville X., Vitoux D., Gauzit R., Combes A., Lahilaire P., and Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 26 (1998) 1536-1544
15. Angstwurm M.W., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., Abel P., et al. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35 (2007) 118-126
16. Heyland D.K., Dhaliwal R., Suchner U., and Berger M.M. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31 (2005) 327-337
17. Vincent J.L., and Forceville X. Critically elucidating the role of selenium. Curr Opin Anaesthesiol 21 (2008) 148-154
18. Köhrle J., Jakob F., Contempré B., and Dumont J.E. Selenium, the thyroid, and the endocrine system. Endocr Rev 26 (2005) 944-984
19. Schomburg L., Riese C., Michaelis M., Griebert E., Klein M.O., Sapin R., et al. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology 147 (2006) 1306-1313
20. Adler S.M., and Wartofsky L. The nonthyroidal illness syndrome. Endocrinol Metab Clin North Am 36 3 (2007) 657-672
21. Gereben B., Zavacki A.M., Ribich S., Kim B.W., Huang S.A., Simonides W.S., et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29 (2008) 898-938
22. Berger M.M., Reymond M.J., Shenkin A., Rey F., Wardle C., Cayeux C., et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med 27 (2001) 91-100
23. Angstwurm M.W., Schopohl J., and Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol 151 (2004) 47-54
24. Nagaya T., Fujieda M., Otsuka G., Yang J.P., Okamoto T., and Seo H.A. potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome. J Clin Invest 106 (2000) 393-402
25. Yu J., and Koenig R.J. Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem 275 (2000) 38296-38301
26. Rodriguez-Perez A., Palos-Paz F., Kaptein E., Visser T.J., Dominguez-Gerpe L., Alvarez-Escudero J., et al. Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clin Endocrinol (Oxford) 68 (2008) 821-827
27. Mebis L., Langouche L., Visser T.J., and Van den Berghe G. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. J Clin Endocrinol Metab 92 (2007) 3330-3333
28. Peeters R.P., Wouters P.J., van Toor H., Kaptein E., Visser T.J., and Van den Berghe G. Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90 (2005) 4559-4565
29. Boelen A., Kwakkel J., Wiersinga W.M., and Fliers E. Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. J Endocrinol 191 (2006) 707-714
30. Fekete C., Sarkar S., Christoffolete M.A., Emerson C.H., Bianco A.C., and Lechan R.M. Lechan RM Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deiodinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels. Brain Res 1056 (2005) 97-99
31. Sanchez E., Singru P.S., Fekete C., and Lechan R.M. Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone. Endocrinology 149 (2008) 2484-2493
32. Boelen A., Platvoet-ter Schiphorst M.C., Bakker O., and Wiersinga W.M. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. J Endocrinol 146 (1995) 475-483